Diabetes Care: 32 (suppl 2)

November 01 2009; volume 32 issue suppl 2

Introduction

You have accessRestricted Access
Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)Dilemmas in clinical practice
Itamar Raz

Diabetes Care 2009 Nov; 32 (suppl 2): S149-S150. https://doi.org/10.2337/dc09-S300

Add to Selected Citations

Diabetes Progression, Prevention, and Treatment

Progression/Prevention
- You have accessRestricted Access
  Defining and Characterizing the Progression of Type 2 Diabetes
  Vivian A. Fonseca
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S151-S156. https://doi.org/10.2337/dc09-S301
  
  Add to Selected Citations
- You have accessRestricted Access
  Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
  Ralph A. DeFronzo and Devjit Tripathy
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S157-S163. https://doi.org/10.2337/dc09-S302
  
  Add to Selected Citations
- You have accessRestricted Access
  Viewpoints on the Way to a Consensus SessionWhere does insulin resistance start? The liver
  Gianluca Perseghin
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S164-S167. https://doi.org/10.2337/dc09-S303
  
  Add to Selected Citations
- You have accessRestricted Access
  Viewpoints on the Way to the Consensus SessionWhere does insulin resistance start? The adipose tissue
  Patricia Iozzo
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S168-S173. https://doi.org/10.2337/dc09-S304
  
  Add to Selected Citations
- You have accessRestricted Access
  Where Does Insulin Resistance Start?The brain
  Uberto Pagotto
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S174-S177. https://doi.org/10.2337/dc09-S305
  
  Add to Selected Citations
- You have accessRestricted Access
  Goals of Treatment for Type 2 Diabetesβ-Cell preservation for glycemic control
  Piero Marchetti, Roberto Lupi, Silvia Del Guerra, Marco Bugliani, Valentina D'Aleo, Margherita Occhipinti, Ugo Boggi, Lorella Marselli and Matilde Masini
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S178-S183. https://doi.org/10.2337/dc09-S306
  
  Add to Selected Citations
- You have accessRestricted Access
  Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 DiabetesPro pharmacologic therapy
  Alan J. Garber
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S184-S188. https://doi.org/10.2337/dc09-S307
  
  Add to Selected Citations
- You have accessRestricted Access
  Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
  Jaakko Tuomilehto
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S189-S193. https://doi.org/10.2337/dc09-S308
  
  Add to Selected Citations
- You have accessRestricted Access
  Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
  Muhammad A. Abdul-Ghani and Ralph A. DeFronzo
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S194-S198. https://doi.org/10.2337/dc09-S309
  
  Add to Selected Citations
- You have accessRestricted Access
  Target for Glycemic ControlConcentrating on glucose
  Louis Monnier and Claude Colette
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S199-S204. https://doi.org/10.2337/dc09-S310
  
  Add to Selected Citations
- You have accessRestricted Access
  Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
  Eleni I. Boutati and Sotirios A. Raptis
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S205-S210. https://doi.org/10.2337/dc09-S312
  
  Add to Selected Citations
- You have accessRestricted Access
  Telemedical Artificial PancreasPARIS (Páncreas Artificial Telemédico Inteligente) research project
  Alberto de Leiva, María Elena Hernando and on behalf of EDUAB-HSP and GBT-UPM
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S211-S216. https://doi.org/10.2337/dc09-S313
  
  Add to Selected Citations
Treatment
- You have accessRestricted Access
  Changing the Treatment Paradigm for Type 2 Diabetes
  Stefano Del Prato, Giuseppe Penno and Roberto Miccoli
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S217-S222. https://doi.org/10.2337/dc09-S314
  
  Add to Selected Citations
- You have accessRestricted Access
  Incretin-Based TherapiesViewpoints on the way to consensus
  Michael. A. Nauck, Tina Vilsbøll, Baptist Gallwitz, Alan Garber and Sten Madsbad
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S223-S231. https://doi.org/10.2337/dc09-S315
  
  Add to Selected Citations
- You have accessRestricted Access
  Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
  Antonio Ceriello and Roberto Testa
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S232-S236. https://doi.org/10.2337/dc09-S316
  
  Add to Selected Citations
- You have accessRestricted Access
  Bile Acids and Metabolic RegulationMechanisms and clinical responses to bile acid sequestration
  Bart Staels and Vivian A. Fonseca
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S237-S245. https://doi.org/10.2337/dc09-S355
  
  Add to Selected Citations
- You have accessRestricted Access
  β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
  Simona Cernea, Raffaella Buzzetti and Paolo Pozzilli
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S246-S252. https://doi.org/10.2337/dc09-S317
  
  Add to Selected Citations
- You have accessRestricted Access
  Insulin Therapy for Type 2 Diabetes
  Sanne G. Swinnen, Joost B. Hoekstra and J. Hans DeVries
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S253-S259. https://doi.org/10.2337/dc09-S318
  
  Add to Selected Citations
- You have accessRestricted Access
  Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic AgentsBasal or prandial insulin? The APOLLO trial and beyond
  Reinhard G. Bretzel, Michael Eckhard, Wolfgang Landgraf, David R. Owens and Thomas Linn
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S260-S265. https://doi.org/10.2337/dc09-S319
  
  Add to Selected Citations
- You have accessRestricted Access
  Early Insulin Treatment in Type 2 DiabetesWhat are the pros?
  Luigi F. Meneghini
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S266-S269. https://doi.org/10.2337/dc09-S320
  
  Add to Selected Citations
- You have accessRestricted Access
  Early Insulin Use in Type 2 DiabetesWhat are the cons?
  Jean-Louis Chiasson
  
  Diabetes Care 2009 Nov; 32 (suppl 2): S270-S274. https://doi.org/10.2337/dc09-S321
  
  Add to Selected Citations

Hypertension and Diabetes Debates

You have accessRestricted Access
How to Define Prehypertension in Diabetes/Metabolic Syndrome
Avshalom Leibowitz and Ehud Grossman

Diabetes Care 2009 Nov; 32 (suppl 2): S275-S279. https://doi.org/10.2337/dc09-S323

Add to Selected Citations
You have accessRestricted Access
Should We Treat Prehypertension in Diabetes?What are the cons?
Ehud Grossman

Diabetes Care 2009 Nov; 32 (suppl 2): S280-S283. https://doi.org/10.2337/dc09-S324

Add to Selected Citations
You have accessRestricted Access
Treatment of Prehypertension in Diabetes and Metabolic SyndromeWhat are the pros?
Julian Segura and Luis M. Ruilope

Diabetes Care 2009 Nov; 32 (suppl 2): S284-S289. https://doi.org/10.2337/dc09-S325

Add to Selected Citations
You have accessRestricted Access
Hypertension and Diabetes: Should We Treat Early Surrogates?What are the cons?
Peter M. Nilsson

Diabetes Care 2009 Nov; 32 (suppl 2): S290-S293. https://doi.org/10.2337/dc09-S329

Add to Selected Citations
You have accessRestricted Access
Hypertension and DiabetesWhat are the pros to treating early surrogates?
Roland E. Schmieder

Diabetes Care 2009 Nov; 32 (suppl 2): S294-S297. https://doi.org/10.2337/dc09-S356

Add to Selected Citations
You have accessRestricted Access
Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
Gianfranco Parati and Grzegorz Bilo

Diabetes Care 2009 Nov; 32 (suppl 2): S298-S304. https://doi.org/10.2337/dc09-S326

Add to Selected Citations
You have accessRestricted Access
Should White-Coat Hypertension in Diabetes Be Treated? Pro
Giuseppe Mancia, Roberto Sega, Michele Bombelli, Fosca Quarti-Trevano, Rita Facchetti and Guido Grassi

Diabetes Care 2009 Nov; 32 (suppl 2): S305-S309. https://doi.org/10.2337/dc09-S327

Add to Selected Citations
You have accessRestricted Access
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Michael Bursztyn and Iddo Z. Ben-Dov

Diabetes Care 2009 Nov; 32 (suppl 2): S310-S313. https://doi.org/10.2337/dc09-S328

Add to Selected Citations

Diabetes and Cardiovascular Disease

You have accessRestricted Access
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Daniele Versari, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni and Stefano Taddei

Diabetes Care 2009 Nov; 32 (suppl 2): S314-S321. https://doi.org/10.2337/dc09-S330

Add to Selected Citations
You have accessRestricted Access
Implications of Postprandial Glucose and Weight Control in People With Type 2 DiabetesUnderstanding and implementing the International Diabetes Federation guidelines
Baptist Gallwitz

Diabetes Care 2009 Nov; 32 (suppl 2): S322-S325. https://doi.org/10.2337/dc09-S331

Add to Selected Citations
You have accessRestricted Access
The Munich Myocardial Infarction RegistryTranslating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
Oliver Schnell, Wolfgang Otter and Eberhard Standl

Diabetes Care 2009 Nov; 32 (suppl 2): S326-S330. https://doi.org/10.2337/dc09-S332

Add to Selected Citations
You have accessRestricted Access
Is Hyperglycemia a Causal Factor in Cardiovascular Disease?Does proving this relationship really matter? Yes
Jaime A. Davidson and Christopher G. Parkin

Diabetes Care 2009 Nov; 32 (suppl 2): S331-S333. https://doi.org/10.2337/dc09-S333

Add to Selected Citations
You have accessRestricted Access
Glucose Control and Cardiovascular DiseaseIs it important? No
Ignacio Conget and Marga Giménez

Diabetes Care 2009 Nov; 32 (suppl 2): S334-S336. https://doi.org/10.2337/dc09-S334

Add to Selected Citations
You have accessRestricted Access
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
Sameer A. Kassem and Itamar Raz

Diabetes Care 2009 Nov; 32 (suppl 2): S337-S341. https://doi.org/10.2337/dc09-S335

Add to Selected Citations
You have accessRestricted Access
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Cristina Bianchi, Roberto Miccoli, Giuseppe Daniele, Giuseppe Penno and Stefano Del Prato

Diabetes Care 2009 Nov; 32 (suppl 2): S342-S348. https://doi.org/10.2337/dc09-S336

Add to Selected Citations
You have accessRestricted Access
Shifting the Disease Management Paradigm From GlucoseWhat are the pros?
Alin Stirban, Diethelm Tschoepe and Bernd Stratmann

Diabetes Care 2009 Nov; 32 (suppl 2): S349-S352. https://doi.org/10.2337/dc09-S337

Add to Selected Citations
You have accessRestricted Access
Shifting the Disease Management Paradigm From GlucoseWhat are the cons?
Markolf Hanefeld, Stefan R. Bornstein and Frank Pistrosch

Diabetes Care 2009 Nov; 32 (suppl 2): S353-S356. https://doi.org/10.2337/dc09-S338

Add to Selected Citations
You have accessRestricted Access
A Summary of the ADVANCE Trial
Simon R. Heller and on behalf of the ADVANCE Collaborative Group*

Diabetes Care 2009 Nov; 32 (suppl 2): S357-S361. https://doi.org/10.2337/dc09-S339

Add to Selected Citations

Obesity and Lipids

You have accessRestricted Access
Adipocytokines and Insulin ResistanceThe possible role of lipocalin-2, retinol binding protein-4, and adiponectin
Eduardo Esteve, Wifredo Ricart and José Manuel Fernández-Real

Diabetes Care 2009 Nov; 32 (suppl 2): S362-S367. https://doi.org/10.2337/dc09-S340

Add to Selected Citations
You have accessRestricted Access
Diabetes Surgery: A New Approach to an Old Disease
Francesco Rubino, Tracy-Ann Moo, Daniel J. Rosen, Greg F. Dakin and Alfons Pomp

Diabetes Care 2009 Nov; 32 (suppl 2): S368-S372. https://doi.org/10.2337/dc09-S341

Add to Selected Citations
You have accessRestricted Access
Triglycerides and HDL CholesterolStars or second leads in diabetes?
Rafael Bitzur, Hofit Cohen, Yehuda Kamari, Aviv Shaish and Dror Harats

Diabetes Care 2009 Nov; 32 (suppl 2): S373-S377. https://doi.org/10.2337/dc09-S343

Add to Selected Citations
You have accessRestricted Access
Should All Diabetic Patients Be Treated With a Statin?
Yehuda Kamari, Rafael Bitzur, Hofit Cohen, Aviv Shaish and Dror Harats

Diabetes Care 2009 Nov; 32 (suppl 2): S378-S383. https://doi.org/10.2337/dc09-S344

Add to Selected Citations
You have accessRestricted Access
American Diabetes Association Indications for Statins in DiabetesIs there evidence?
Roy Eldor and Itamar Raz

Diabetes Care 2009 Nov; 32 (suppl 2): S384-S391. https://doi.org/10.2337/dc09-S345

Add to Selected Citations
You have accessRestricted Access
Fat or Fit: What Is More Important?
Vojtech Hainer, Hermann Toplak and Vladimír Stich

Diabetes Care 2009 Nov; 32 (suppl 2): S392-S397. https://doi.org/10.2337/dc09-S346

Add to Selected Citations
You have accessRestricted Access
Obesity in Elderly SubjectsIn sheep's clothing perhaps, but still a wolf!
Etty Osher and Naftali Stern

Diabetes Care 2009 Nov; 32 (suppl 2): S398-S402. https://doi.org/10.2337/dc09-S347

Add to Selected Citations
You have accessRestricted Access
Obesity in the Elderly Diabetic PatientIs weight loss beneficial? No
Ioannis Kyrou and Constantine Tsigos

Diabetes Care 2009 Nov; 32 (suppl 2): S403-S409. https://doi.org/10.2337/dc09-S348

Add to Selected Citations

Diagnosis and Treatment of Microvascular Disease

You have accessRestricted Access
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Mordchai Ravid

Diabetes Care 2009 Nov; 32 (suppl 2): S410-S413. https://doi.org/10.2337/dc09-S349

Add to Selected Citations
You have accessRestricted Access
Painful Diabetic NeuropathyAdvantage of novel drugs over old drugs?
Dan Ziegler

Diabetes Care 2009 Nov; 32 (suppl 2): S414-S419. https://doi.org/10.2337/dc09-S350

Add to Selected Citations
You have accessRestricted Access
Microvascular Complications in Diabetic Erectile DysfunctionDo we need other alternatives?
Yoram Vardi

Diabetes Care 2009 Nov; 32 (suppl 2): S420-S422. https://doi.org/10.2337/dc09-S351

Add to Selected Citations

Smoking

You have accessRestricted Access
Smoking Cessation: It Is Never Too Late
Peter M. Nilsson and Karl-Olov Fagerström

Diabetes Care 2009 Nov; 32 (suppl 2): S423-S425. https://doi.org/10.2337/dc09-S352

Add to Selected Citations
You have accessRestricted Access
Why Won't Our Patients Stop Smoking?The power of nicotine addiction
David M. Mannino

Diabetes Care 2009 Nov; 32 (suppl 2): S426-S428. https://doi.org/10.2337/dc09-S353

Add to Selected Citations
You have accessRestricted Access
Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
Robert H. Fagard

Diabetes Care 2009 Nov; 32 (suppl 2): S429-S431. https://doi.org/10.2337/dc09-S354

Add to Selected Citations

Main menu

User menu

Search

Table of Contents

Introduction

Diabetes Progression, Prevention, and Treatment

Progression/Prevention

Treatment

Hypertension and Diabetes Debates

Diabetes and Cardiovascular Disease

Obesity and Lipids

Diagnosis and Treatment of Microvascular Disease

Smoking

In this Issue

Jump to

Navigate

More Information

Other ADA Resources